Data presented at ARVO 2026 show that high-dose gene therapy boosts central retinal sensitivity in X-linked retinitis ...
Data show promising and sustained improvements across key measures of visual function, including low luminance visual acuity and mean macular ...
17h
From touch to vision: A bioinspired multisensory framework brings human-like perception to robots
This study presents a bioinspired multisensory framework that integrates vision, touch, hearing, smell, and taste within a self-powered architecture. By enabling cross-modal association and adaptive ...
WILMINGTON, DE - May 04, 2026 - PRESSADVANTAGE - The G-Stacker platform is available as a digital infrastructure system ...
National Firewatch reports extreme weather increases power outages, jeopardizing fire safety systems, necessitating proactive ...
Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...
A three-terminal light-emitting memristor lets display pixels store memory, process signals, and emit light for faster local ...
Oral presentation at ISCT 2026 included larger 52-week follow-up cohort, with 52% of evaluable patients achieving at least 50% improvement in ...
Discusses Strategic Focus on Izicopan for ANCA-Associated Vasculitis and Renal Diseases May 8, 2026 8:30 AM EDTCompany ...
Discusses BGE-102 Clinical Results and Development Strategy for Cardiovascular and Retinal Disease May 8, 2026 12:30 PM ...
Sinéad Burke and the Met opened the Gala carpet to Disabled guests and named "The Disabled Body" inside Costume Art. Inside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results